Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 304,633 clinical trials worldwide
Search
Showing 128651-128700 of 304,633 trials
Active filters:
Status: Completed
Clinical Trials (304,633)
NCT03256435
Retention in PrEP Care for African American MSM in Mississippi
NA
Completed
70 participants
Started: Sep 7, 2016 · Completed: May 31, 2021
2 conditions
3 sponsors
1 location
NCT03680638
The Effect of Antioxidants on Skin Blood Flow During Local Heating
PHASE1
Completed
44 participants
Started: Sep 7, 2016 · Completed: Oct 9, 2017
3 conditions
1 sponsor
1 location
NCT03235947
Perioperative Fosfomycin in the Prophylaxis of Urinary Tract Infection in Kidney Transplant Recipients
PHASE4
Completed
82 participants
Started: Sep 7, 2016 · Completed: Nov 6, 2017
2 conditions
2 sponsors
1 location
NCT02798861
Controlled Attenuation Parameter (CAP) in Liver Allografts
N/A
Completed
160 participants
Started: Sep 7, 2016 · Completed: Jun 1, 2019
5 conditions
1 sponsor
3 locations
NCT04235894
An Observer Rating Scale of Facial Expression Can Predict Dreaming in Propofol Anesthesia
N/A
Completed
124 participants
Started: Sep 7, 2016 · Completed: Oct 18, 2017
3 conditions
2 sponsors
0 locations
NCT02855008
Steps to Effective Problem Solving in Group Homes
NA
Completed
211 participants
Started: Sep 7, 2016 · Completed: Oct 31, 2022
1 condition
2 sponsors
1 location
NCT02864394
Study of Pembrolizumab Versus Docetaxel in Participants Previously Treated for Non-Small Cell Lung Cancer (MK-3475-033/KEYNOTE-033)
PHASE3
Completed
425 participants
Started: Sep 7, 2016 · Completed: Oct 14, 2022
1 condition
1 sponsor
0 locations
NCT03617276
Reliability of Functional Outcome Measures in Neurofibromatosis 2
N/A
Completed
30 participants
Started: Sep 7, 2016 · Completed: May 17, 2017
1 condition
1 sponsor
1 location
NCT02815670
Reversal Dabigatran Anticoagulant Effect With Idarucizumab
PHASE3
Completed
1 participants
Started: Sep 7, 2016 · Completed: Oct 19, 2019
1 condition
1 sponsor
2 locations
NCT02824042
Thorough ECG (Electrocardiogram) and Drug Interaction Study With Anetumab Ravtansine and Itraconazole
PHASE1
Completed
63 participants
Started: Sep 7, 2016 · Completed: Aug 5, 2019
1 condition
1 sponsor
18 locations
NCT05178745
Resection Observatory
N/A
Completed
140 participants
Started: Sep 7, 2016 · Completed: May 27, 2022
2 conditions
1 sponsor
0 locations
NCT02776735
An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)
PHASE2
Completed
102 participants
Started: Sep 6, 2016 · Completed: Dec 27, 2023
1 condition
2 sponsors
30 locations
NCT03239847
Cost Effectiveness of the EndoPhys Pressure Sensing Access System vs. Radial A-line for Intra-operative Blood Pressure Monitoring
NA
Completed
40 participants
Started: Sep 6, 2016 · Completed: Apr 5, 2017
1 condition
1 sponsor
0 locations
NCT02896257
De-implementing Inhaled Steroids to Improve Care and Safety in COPD
NA
Completed
181 participants
Started: Sep 6, 2016 · Completed: Jun 30, 2021
1 condition
1 sponsor
2 locations
NCT02894398
Study in Women With Advanced Breast Cancer Receiving Palbociclib With AI or Fulvestrant
PHASE2
Completed
388 participants
Started: Sep 6, 2016 · Completed: Feb 15, 2023
3 conditions
2 sponsors
70 locations
NCT02768389
Feasibility Trial of the Modified Atkins Diet and Bevacizumab for Recurrent Glioblastoma
EARLY_PHASE1
Completed
18 participants
Started: Sep 6, 2016 · Completed: Nov 30, 2018
2 conditions
3 sponsors
4 locations
NCT04319770
Effectiveness of Hyaluronic Acid in the Regeneration of Infrabony Defects
NA
Completed
32 participants
Started: Sep 6, 2016 · Completed: Oct 21, 2019
1 condition
1 sponsor
0 locations
NCT06827392
Photoprotection Efficiency with Sunscreen Formulas Under Visible Light Exposure.
N/A
Completed
20 participants
Started: Sep 6, 2016 · Completed: Oct 7, 2016
2 conditions
1 sponsor
1 location
NCT02824224
Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS)
PHASE4
Completed
42 participants
Started: Sep 6, 2016 · Completed: Jan 8, 2018
3 conditions
1 sponsor
1 location
NCT04492423
VerifyNow® PRUTest® Cardiovascular Population Expected Values On-Drug Study
N/A
Completed
100 participants
Started: Sep 6, 2016 · Completed: Mar 22, 2018
2 conditions
1 sponsor
0 locations
NCT04105751
Testing a Novel Manual Communication System for Mechanically Ventilated ICU Patients
NA
Completed
27 participants
Started: Sep 6, 2016 · Completed: Aug 20, 2019
2 conditions
2 sponsors
1 location
NCT02867267
The Efficacy and Safety of Ta1 for Sepsis
PHASE3
Completed
1,106 participants
Started: Sep 6, 2016 · Completed: Mar 23, 2021
1 condition
2 sponsors
22 locations
NCT03686826
Feasibility and Reliability of Multimodal Evoked Potentials
N/A
Completed
40 participants
Started: Sep 6, 2016 · Completed: Dec 31, 2018
1 condition
1 sponsor
1 location
NCT02904902
Open-label Study of Adalimumab in Japanese Subjects With Hidradenitis Suppurativa
PHASE3
Completed
15 participants
Started: Sep 6, 2016 · Completed: May 30, 2019
1 condition
1 sponsor
8 locations
NCT03482154
Malglycemia in the Pediatric Hematopoietic Stem Cell Transplant Population
N/A
Completed
344 participants
Started: Sep 6, 2016 · Completed: Jun 30, 2019
3 conditions
1 sponsor
1 location
NCT02916979
Myeloid-Derived Suppressor Cells and Checkpoint Immune Regulators' Expression in Allogeneic SCT Using FluBuATG
PHASE1
Completed
20 participants
Started: Sep 6, 2016 · Completed: Feb 11, 2022
7 conditions
1 sponsor
1 location
NCT02848326
Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention
PHASE2/PHASE3
Completed
834 participants
Started: Sep 6, 2016 · Completed: Apr 23, 2018
1 condition
1 sponsor
75 locations
NCT03114761
CTA for Internal Herniation After RYGB Surgery
NA
Completed
12 participants
Started: Sep 5, 2016 · Completed: Jan 30, 2018
1 condition
1 sponsor
1 location
NCT02750579
Early or Delayed Revascularization for Intermediate and High-risk Non ST-elevation Acute Coronary Syndromes?
NA
Completed
740 participants
Started: Sep 5, 2016 · Completed: Apr 30, 2018
1 condition
1 sponsor
1 location
NCT02872597
Phase I, Placebo-Controlled, Blinded Pilot Study of Ipratropium in Children Admitted to the ICU With Status Asthmaticus
PHASE1
Completed
30 participants
Started: Sep 5, 2016 · Completed: Aug 16, 2018
1 condition
1 sponsor
1 location
NCT03035370
Viaskin Pertussis Vaccine Trial
PHASE1
Completed
102 participants
Started: Sep 5, 2016 · Completed: Apr 25, 2018
1 condition
2 sponsors
1 location
NCT02913027
Can We Improve the Comfort of Pelvic Exams?
NA
Completed
200 participants
Started: Sep 5, 2016 · Completed: Mar 30, 2017
1 condition
1 sponsor
0 locations
NCT03508349
Routine Antenatal Care Versus Screening and Treatment of Malaria in Pregnancy in Rwanda
NA
Completed
1,786 participants
Started: Sep 5, 2016 · Completed: Mar 18, 2019
1 condition
3 sponsors
14 locations
NCT02924155
Clinical Study to Investigate the Systemic Exposure, Safety, and Local Tolerability of SJP002 Ophthalmic Solution in Healthy Male Volunteers
PHASE1
Completed
12 participants
Started: Sep 5, 2016 · Completed: Nov 17, 2016
1 condition
1 sponsor
1 location
NCT03170921
Psychophysiological Characterization of Different Capoeira Performances in Experienced Individuals
NA
Completed
11 participants
Started: Sep 5, 2016 · Completed: Sep 16, 2016
3 conditions
1 sponsor
0 locations
NCT02812706
Isatuximab Single Agent Study in Japanese Relapsed AND Refractory Multiple Myeloma Patients
PHASE1/PHASE2
Completed
36 participants
Started: Sep 5, 2016 · Completed: Sep 28, 2022
1 condition
1 sponsor
13 locations
NCT02874807
Effects of the SGLT2-inhibitor Empagliflozin on Patients With SIADH - the SAND Study
PHASE2/PHASE3
Completed
88 participants
Started: Sep 5, 2016 · Completed: Jan 14, 2019
1 condition
1 sponsor
1 location
NCT03341338
Genes-in-Action - Hepcidin Regulation of Iron Supplementation
N/A
Completed
206 participants
Started: Sep 5, 2016 · Completed: Apr 29, 2019
1 condition
2 sponsors
1 location
NCT03360877
Prevention of Nosocomial Infections (CleanKids)
NA
Completed
4,944 participants
Started: Sep 5, 2016 · Completed: Jun 30, 2019
3 conditions
3 sponsors
0 locations
NCT02892409
TAK-438 Bismuth Drug Interaction Study
PHASE1
Completed
30 participants
Started: Sep 5, 2016 · Completed: May 11, 2017
1 condition
1 sponsor
1 location
NCT05112068
Comparative Assessment of Effectiveness and Safety of Methods for Skin and Hair Care in Severe Intensive Care Unit Patients
N/A
Completed
60 participants
Started: Sep 4, 2016 · Completed: Aug 11, 2017
1 condition
1 sponsor
1 location
NCT03309566
Bioequivalence Study of Two Formulatiosns With the Asscociaton of Efavirenz, Emtricitabine and Tenofovir
PHASE4
Completed
24 participants
Started: Sep 4, 2016 · Completed: Feb 28, 2017
1 condition
1 sponsor
1 location
NCT04127461
Endoscopic Harvesting in Coronary Artery Bypass Grafting.
NA
Completed
773 participants
Started: Sep 3, 2016 · Completed: Dec 31, 2018
2 conditions
2 sponsors
0 locations
NCT02888210
A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery
PHASE3
Completed
110 participants
Started: Sep 3, 2016 · Completed: Nov 22, 2017
1 condition
1 sponsor
1 location
NCT04282655
Effect of Milk Warming on the Very Low Birth Weight Infant
NA
Completed
44 participants
Started: Sep 2, 2016 · Completed: Mar 30, 2019
3 conditions
1 sponsor
1 location
NCT03176966
Ropinirole for the Treatment of Muscle Cramps in Patients With Cirrhosis
PHASE4
Completed
31 participants
Started: Sep 2, 2016 · Completed: Oct 22, 2021
2 conditions
1 sponsor
1 location
NCT04106661
Tai Chi as Physical Activity for Women With Morbid Obesity
NA
Completed
17 participants
Started: Sep 2, 2016 · Completed: Nov 21, 2017
1 condition
1 sponsor
0 locations
NCT03039023
Effects of Choline From Eggs vs. Supplements on the Generation of TMAO in Humans
NA
Completed
86 participants
Started: Sep 2, 2016 · Completed: Sep 3, 2020
1 condition
1 sponsor
1 location
NCT03078439
EPIPAGE2 Cohort Study Follow up at Five and a Half Years
N/A
Completed
3,404 participants
Started: Sep 2, 2016 · Completed: Jan 8, 2018
1 condition
1 sponsor
98 locations
NCT02841579
Osimertinib (AZD9291) in First-line Locally Advanced or Metastatic NSCLC Patients With EGFR and EGFR T790M
PHASE2
Completed
22 participants
Started: Sep 2, 2016 · Completed: Feb 14, 2020
1 condition
2 sponsors
7 locations
Previous
1
More pages
2571
2572
2573
2574
2575
2576
2577
More pages
6093
Next